pioglitazone has been researched along with threonine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, MG; Cavallo, MG; Fanelli, M; Filippi, E; Romeo, S; Sentinelli, F | 1 |
| Atkins, KB; Brosius, FC; Irey, B; Xiang, N | 1 |
2 other study(ies) available for pioglitazone and threonine
| Article | Year |
|---|---|
The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
Topics: 3T3 Cells; Adipocytes; Animals; Cell Differentiation; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Mice; Mitogen-Activated Protein Kinases; Mutation; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Pioglitazone; PPAR gamma; Serine; Signal Transduction; Thiazolidinediones; Threonine; Transfection; Tyrosine | 2006 |
A rapid, PPAR-gamma-dependent effect of pioglitazone on the phosphorylation of MYPT.
Topics: Amides; Anilides; Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Hypoglycemic Agents; Muscle, Smooth, Vascular; Myosin-Light-Chain Kinase; Phosphorylation; Pioglitazone; PPAR gamma; Protein Phosphatase 1; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Thiazolidinediones; Threonine | 2009 |